TGFB1 and neoplasm: Noncanonical pathways involves Wnt/β-catenin, PI3K/Akt, RhoA/ROCK1, MAPK/p38 or MAPK/ERK1/2 that mediate different effect of TGF-β on different tumor cells [15,16,17].